Quantcast
Last updated on April 16, 2014 at 12:40 EDT

Latest Medigus Ltd. Stories

2014-03-19 08:28:57

OMER, Israel, March 19, 2014 /PRNewswire/ -- Medigus Ltd. (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and procedures announced today that two oral presentations will highlight the MUSE(TM) System at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) annual meeting, taking place April 2 - 5, 2014 at the Salt Palace Convention Center, Salt Lake City, Utah. Medigus is exhibiting at booth # 1113....

2014-02-25 08:31:17

-Company Scheduled to Present on March 11, 2014 at 2:30 p.m. PT- OMER, Israel, Feb. 25, 2014 /PRNewswire/ -- Medigus Ltd. (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and procedures, announced today that Chris Rowland CEO, will present at the 26th Annual ROTH Conference at 2:30 p.m. PT, on March 11, 2014 in Track 6: Salon 6. The conference will be held on March 9-12, 2014 at the Ritz Carlton, 1 Ritz Carlton Drive, Dana Point, California. A...

2014-02-12 04:21:03

-MUSE(TM) offers millions of patients with reflux durable relief and the potential to eliminate the use of lifelong medication helping reduce healthcare costs- OMER, Israel, Feb. 12, 2014 /PRNewswire/ -- Medigus Ltd. (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and procedures, reveals additional details regarding its commercial strategy, including rebranding its flagship product MUSE(TM), formerly the SRS System. Through this strategy, CEO Chris...

2014-01-07 12:29:02

OMER, Israel, Jan. 7, 2014 /PRNewswire/ -- Medigus Ltd. (TASE: MDGS) announced today that Mr. Chris Rowland, CEO, will present at the 16(th) Annual Needham Growth Conference taking place at The New York Palace Hotel in New York City January 14 - 16, 2014. Mr. Rowland's presentation is scheduled for Wednesday, January 15, 2014 at 12:05 p.m. EST. To access a live webcast of this presentation, visit http://wsw.com/webcast/needham64/mdgs.ta. An archived recording will also be available...

2013-07-02 08:27:47

OMER, Israel, July 2, 2013 /PRNewswire/ -- Medigus Ltd (TASE:MDGS) announced today that it had approved the first order for SRS(TM) systems in the United States. The systems are expected to be used in procedures for the treatment of gastroesophageal reflux disease (GERD) at Columbia University Medical Center - New York Presbyterian Hospital during the next several weeks, constituting the first commercial use of the SRS(TM) system in the United States. (Logo:...

2013-05-16 12:31:06

OMER, Israel, May 16, 2013 /PRNewswire/ -- Medigus Ltd. (TASE:MDGS), a leading medical device company dedicated to the development of innovative endoscopic procedures and technologies, will be presenting the successful three year follow-up data of the SRS(TM) pivotal study at the Digestive Disease Week in Orlando on May 18-21st 2013. (Logo: http://photos.prnewswire.com/prnh/20130313/601331 ) The study that was conducted in Indiana University, a leading U.S...

2013-03-18 08:31:24

Sinopharm to Purchase SRS(TM) II Systems for a Minimum of $3.85 Million in the in the First Two Years of the Agreement OMER, Israel, March 18, 2013 /PRNewswire/ -- Medigus Ltd. (TASE:MDGS), a leading medical device company dedicated to the development of innovative endoscopic procedures and technologies, announced today that it has signed a distribution agreement for SRS(TM)II Systems in China with China National Pharmaceutical Group Corporation (Sinopharm). (Logo:...

2013-03-13 12:34:43

OMER, Israel, March 13, 2013 /PRNewswire/ -- Medigus [http://www.medigus.com ] Ltd. (TASE:MDGS), a leading medical device company dedicated to the development of innovative endoscopic procedures and technologies, announced today the closing of a private equity placement of $8 million to OrbiMed Israel Partners Limited Partnership, an affiliate of OrbiMed Advisors LLC, a leading healthcare investment firm. OrbiMed has been issued 39.9 million ordinary shares of Medigus, which...

2012-05-24 02:28:25

OMER, Israel, May 24, 2012 /PRNewswire/ -- The SRS system by Medigus, offers endoluminal treatment for one of the most common chronic conditions Medigus Ltd. [http://www.medigus.com ] (TASE: MDGS) announced that it has received FDA 510(k) marketing clearance for its SRS endoscopic system. (Photo: http://photos.prnewswire.com/prnh/20120524/533495 ) (Logo: http://photos.prnewswire.com/prnh/20120524/533495-logo ) The SRS device is intended for...

2011-05-03 06:12:00

OMER, Israel, May 3, 2011 /PRNewswire-FirstCall/ -- Medigus Ltd. (TASE: MDGS) has developed the world's smallest video camera - just 0.99 mm in diameter. These miniature cameras are manufactured from materials suitable for human medical procedures. They are designed specifically for small-diameter disposable endoscopic devices, used in diagnostic and surgical procedures in regions of the anatomy where larger scopes are not viable. Medical fields in which such tools are required...